These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7511673)

  • 1. Inhibition of experimental autoimmune encephalomyelitis by MHC class II binding competitor peptides depends on the relative MHC binding affinity of the disease-inducing peptide.
    Wauben MH; Joosten I; Schlief A; van der Zee R; Boog CJ; van Eden W
    J Immunol; 1994 Apr; 152(8):4211-20. PubMed ID: 7511673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of entire myelin basic protein-induced experimental autoimmune encephalomyelitis in Lewis rats by major histocompatibility complex class II-binding competitor peptides.
    Wauben MH; Kozhich A; Joosten I; Schlief A; Boog CJ; van Eden W
    Eur J Immunol; 1994 May; 24(5):1053-60. PubMed ID: 7514128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAs molecules.
    Lamont AG; Sette A; Fujinami R; Colón SM; Miles C; Grey HM
    J Immunol; 1990 Sep; 145(6):1687-93. PubMed ID: 1697306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of a potent cyclic analogue of the myelin basic protein epitope MBP72-85: importance of the Ala81 carboxyl group and of a cyclic conformation for induction of experimental allergic encephalomyelitis.
    Tselios T; Probert L; Daliani I; Matsoukas E; Troganis A; Gerothanassis IP; Mavromoustakos T; Moore GJ; Matsoukas JM
    J Med Chem; 1999 Apr; 42(7):1170-7. PubMed ID: 10197961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II.
    Abromson-Leeman S; Alexander J; Bronson R; Carroll J; Southwood S; Dorf M
    J Immunol; 1995 Jan; 154(1):388-98. PubMed ID: 7527816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self and non-self peptides treat autoimmune encephalomyelitis: T cell anergy or competition for major histocompatibility complex class II binding?
    Gautam AM
    Eur J Immunol; 1995 Jul; 25(7):2059-63. PubMed ID: 7542603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of experimental autoimmune myasthenia gravis by major histocompatibility complex class II competitor peptides results not only in a suppressed but also in an altered immune response.
    Wauben MH; Hoedemaekers AC; Graus YM; Wagenaar JP; van Eden W; de Baets MH
    Eur J Immunol; 1996 Dec; 26(12):2866-75. PubMed ID: 8977279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coculture of TCR peptide-specific T cells with basic protein-specific T cells inhibits proliferation, IL-3 mRNA, and transfer of experimental autoimmune encephalomyelitis.
    Offner H; Vainiene M; Celnik B; Weinberg AD; Buenafe A; Vandenbark AA
    J Immunol; 1994 Dec; 153(11):4988-96. PubMed ID: 7525721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective influences on experimental autoimmune encephalomyelitis by MHC class I and class II alleles.
    Mustafa M; Vingsbo C; Olsson T; Issazadeh S; Ljungdahl A; Holmdahl R
    J Immunol; 1994 Oct; 153(7):3337-44. PubMed ID: 7522259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of experimental autoimmune encephalomyelitis by a nonimmunogenic non-self peptide that binds to I-Au.
    Gautam AM; Pearson CI; Sinha AA; Smilek DE; Steinman L; McDevitt HO
    J Immunol; 1992 May; 148(10):3049-54. PubMed ID: 1578131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical requirement for aspartic acid at position 82 of myelin basic protein 73-86 for recruitment of V beta 8.2+ T cells and encephalitogenicity in the Lewis rat.
    Smeltz RB; Wauben MH; Wolf NA; Swanborg RH
    J Immunol; 1999 Jan; 162(2):829-36. PubMed ID: 9916705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major role of antigen-presenting cells in the response of rat encephalitogenic T cells to myelin basic proteins.
    Sun D; Le J; Yang S; Malotkey M; Coleclough C
    J Immunol; 1993 Jul; 151(1):111-8. PubMed ID: 7686928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major histocompatibility complex-controlled protective influences on experimental autoimmune encephalomyelitis are peptide specific.
    Issazadeh S; Kjellén P; Olsson T; Mustafa M; Holmdahl R
    Eur J Immunol; 1997 Jun; 27(6):1584-7. PubMed ID: 9209515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parental MHC molecule haplotype expression in (SJL/J x SWR)F1 mice with acute experimental allergic encephalomyelitis induced with two different synthetic peptides of myelin proteolipid protein.
    Sobel RA; Tuohy VK; Lees MB
    J Immunol; 1991 Jan; 146(2):543-9. PubMed ID: 1702806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis.
    Burrows GG; Bebo BF; Adlard KL; Vandenbark AA; Offner H
    J Immunol; 1998 Dec; 161(11):5987-96. PubMed ID: 9834080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and genetic requirements for preferential recruitment of TCRBV8S2+ T cells in Lewis rat experimental autoimmune encephalomyelitis.
    Weissert R; Svenningsson A; Lobell A; de Graaf KL; Andersson R; Olsson T
    J Immunol; 1998 Jan; 160(2):681-90. PubMed ID: 9551903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive inhibition of antigen presentation in animal models of autoimmune disease.
    Lock C; Smilek D; Gautam A; Vaysburd M; Dwivedy S; McDevitt H
    Semin Immunol; 1991 Jul; 3(4):247-55. PubMed ID: 1718485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long-lived peptide-MHC complexes.
    Samson MF; Smilek DE
    J Immunol; 1995 Sep; 155(5):2737-46. PubMed ID: 7544383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of rat encephalitogenic T lymphocyte lines to synthetic peptides of myelin basic protein.
    Offner H; Hashim G; Vandenbark AA
    J Neurosci Res; 1987; 17(4):344-8. PubMed ID: 2442405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encephalitogenic and proliferative responses of Lewis rat lymphocytes distinguished by position 75- and 80-substituted peptides of myelin basic protein.
    Mannie MD; Paterson PY; U'Prichard DC; Flouret G
    J Immunol; 1989 Apr; 142(8):2608-16. PubMed ID: 2467932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.